Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Filings indexed 1,200 across all filing types
Latest filing 2021-06-10 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement notice about transferring equity shares to the Investor Education and Protection Fund (IEPF) pursuant to a section of the Companies Act. It is a regulatory compliance announcement related to share transfers and does not contain financial statements, management discussion, or detailed financial data. The document length is short (1414 characters) and it is an announcement of a notice published in newspapers. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and compliance document, not a full report or financial filing.
2021-06-10 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement dated May 27, 2021, addressed to stock exchanges regarding the allotment of shares under the company's ESOP 2016 Plan. It details the number of shares allotted, the increase in paid-up share capital, and confirms that the new shares rank pari passu with existing shares. There is no financial data, no detailed report, no regulatory certification, or voting results. The document is an announcement of a capital change due to share allotment under an employee stock option plan. Given the content and length (1170 characters), this fits the category of Share Issue/Capital Change (SHA).
2021-05-27 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the grant of stock options under the company's ESOP plan. It details the number of options granted, exercise price, vesting period, and exercisable period. This is a clear announcement of a share-based compensation event, specifically the granting of stock options to employees. It does not contain financial statements, audit information, or meeting materials. It is not a report or a regulatory filing about voting or dividends. The content fits the category of a share issue or capital change announcement, as it relates to the issuance of stock options which affect the company's capital structure.
2021-05-27 English
Dividend
Notice of Dividend Amount Classification · 100% confidence The document is a letter dated May 27, 2021, addressed to stock exchanges, announcing the outcome of a board meeting where the Board of Directors recommended a final dividend for the financial year ended March 31, 2021. It specifies the dividend amount per share and mentions the payment timeline contingent on shareholder approval at the upcoming AGM. The content is a formal announcement of dividend recommendation and payment details, not a full report or financial statement. The document length is short (1058 characters), and it clearly focuses on dividend information. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2021-05-27 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed communication from Strides Pharma Science Limited dated May 27, 2021, reporting the audited financial results for the quarter and year ended March 31, 2021. It includes comprehensive financial data such as revenues, EBITDA, profit after tax, earnings per share, segment-wise performance, and commentary from the Managing Director & CEO. The document also contains detailed analysis of COVID-19 impacts, future plans, and operational highlights. The presence of full financial statements and extensive financial performance discussion indicates this is a comprehensive financial report for a full fiscal year. The document is not merely an announcement or a brief summary but contains substantive financial data and analysis. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2021
2021-05-27 English
Press Release
Investor Presentation Classification · 85% confidence The document is a press release announcing a partnership and product launch related to liposomal amphotericin B in India. It includes details about regulatory approval, product distribution, and company statements. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is a corporate announcement intended for public and investor information, typical of a press release or investor communication. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Investor Presentation (IP) since it provides detailed information for investors about the partnership, product launch, and market context, although it is not a formal presentation deck, it aligns best with investor communication rather than other categories.
2021-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.